about
Cancer cells mimic in vivo spatial-temporal cell-cycle phase distribution and chemosensitivity in 3-dimensional GelfoamĀ® histoculture but not 2-dimensional culture as visualized with real-time FUCCI imaging.Establishment of a Non-Invasive Semi-Quantitative Bioluminescent Imaging Method for Monitoring of an Orthotopic Esophageal Cancer Mouse ModelA simple biological imaging system for detecting viable human circulating tumor cells.Establishment of a pancreatic stem cell line from fibroblast-derived induced pluripotent stem cells.Spatial-temporal FUCCI imaging of each cell in a tumor demonstrates locational dependence of cell cycle dynamics and chemoresponsivenessMolecular diagnosis and therapy for occult peritoneal metastasis in gastric cancer patientsInvading cancer cells are predominantly in G0/G1 resulting in chemoresistance demonstrated by real-time FUCCI imagingBiological ablation of sentinel lymph node metastasis in submucosally invaded early gastrointestinal cancer.The role of nicotinamide adenine dinucleotide phosphate oxidase-derived reactive oxygen species in the acquisition of metastatic ability of tumor cellsTumor-targeting Salmonella typhimurium A1-R decoys quiescent cancer cells to cycle as visualized by FUCCI imaging and become sensitive to chemotherapyAdvances in adenovirus-mediated p53 cancer gene therapy.Fluorescence virus-guided capturing system of human colorectal circulating tumour cells for non-invasive companion diagnostics.Fascin regulates chronic inflammation-related human colon carcinogenesis by inhibiting cell anoikis.A genetically engineered oncolytic adenovirus decoys and lethally traps quiescent cancer stem-like cells in S/G2/M phases.Chronic inflammation-derived nitric oxide causes conversion of human colonic adenoma cells into adenocarcinoma cells.A protein transduction method using oligo-arginine (3R) for the delivery of transcription factors into cell nuclei.A simple detection system for adenovirus receptor expression using a telomerase-specific replication-competent adenovirus.Impact of Autophagy in Oncolytic Adenoviral Therapy for Cancer.Preclinical evaluation of telomerase-specific oncolytic virotherapy for human bone and soft tissue sarcomas.Role of zoledronic acid in oncolytic virotherapy: Promotion of antitumor effect and prevention of bone destruction.Viral transduction of the HER2-extracellular domain expands trastuzumab-based photoimmunotherapy for HER2-negative breast cancer cells.Liposome-encapsulated plasmid DNA of telomerase-specific oncolytic adenovirus with stealth effect on the immune system.Dual programmed cell death pathways induced by p53 transactivation overcome resistance to oncolytic adenovirus in human osteosarcoma cells.Involvement of reactive nitrogen oxides for acquisition of metastatic properties of benign tumors in a model of inflammation-based tumor progression.Loss of p53 in stromal fibroblasts enhances tumor cell proliferation through nitric-oxide-mediated cyclooxygenase 2 activation.In vivo biological purging for lymph node metastasis of human colorectal cancer by telomerase-specific oncolytic virotherapy.Mouse strain differences in inflammatory responses of colonic mucosa induced by dextran sulfate sodium cause differential susceptibility to PhIP-induced large bowel carcinogenesis.Anti-high mobility group box 1 monoclonal antibody improves ischemia/reperfusion injury and mode of liver regeneration after partial hepatectomy.Oxidative and nitrative stress caused by subcutaneous implantation of a foreign body accelerates sarcoma development in Trp53+/- mice.Genetically engineered oncolytic adenovirus induces autophagic cell death through an E2F1-microRNA-7-epidermal growth factor receptor axis.Suppression of thymic lymphomas and increased nonthymic lymphomagenesis in Trp53-deficient mice lacking inducible nitric oxide synthase gene.Integrated fluorescent cytology with nano-biologics in peritoneally disseminated gastric cancerPD-L1 expression combined with microsatellite instability/CD8+ tumor infiltrating lymphocytes as a useful prognostic biomarker in gastric cancerA Novel Combination Cancer Therapy with Iron Chelator Targeting Cancer Stem Cells via Suppressing StemnessIncreased risk of intestinal type of gastric adenocarcinoma in Japanese women associated with long forms of CCTTT pentanucleotide repeat in the inducible nitric oxide synthase promoterBone and Soft-Tissue Sarcoma: A New Target for Telomerase-Specific Oncolytic VirotherapyVisualization of epithelial-mesenchymal transition in an inflammatory microenvironment-colorectal cancer networkIntraperitoneal cancer-immune microenvironment promotes peritoneal dissemination of gastric cancer
P50
Q27311397-D2D3B691-9C7B-4FA9-A617-711F73695FDBQ27321510-711060A7-9D71-466C-92D8-646EAD4DFC6AQ30490534-467AABB2-C2E3-4CBD-A5A1-AD9819FD929EQ33746955-B50FF3CA-166D-48C4-8D2E-DE028259FD1CQ33952918-82C310FA-EB99-4E70-A162-F925D7B51174Q34750564-49FBF240-CF10-4EDA-95AE-B762F2C98418Q35098274-0656760C-1F15-401A-B284-8240F66F0B3EQ35153125-256E1BB2-D51E-4A54-8744-B8CA8E669A26Q35221860-824C722C-9F90-4CEB-9A1E-36C67487C66BQ36189385-1B7FF54D-1D6B-4714-AEAE-E9DCAF399C89Q38150910-F36BEAC4-33A7-4D12-A1F6-FA30A48FE3A9Q38990791-9E0EB01F-E823-46D5-AD56-B88F0362E16FQ39020527-81C467C0-B593-456F-9B76-41FEFABF4010Q39089458-823B5CF0-C2C8-4CFA-AE0B-1D285DFB3D39Q39109978-520AB12C-2577-4AC2-A378-BD38498BD7DBQ39371515-AD4FCBFE-D9A6-46E2-A594-97890EA0735CQ39413029-20542F21-1A09-4969-9944-1C1B9427EFA8Q39429511-26C2EF8B-0B03-4330-AD05-AA1B86D62CBCQ39591333-2EFEEDF4-B30C-4A5E-BEC5-6D105230A590Q41595578-37331670-BEFD-46A6-9E60-DE32726382D8Q42174238-FF5E3746-0B8A-43BF-9FC7-8131F73A16D1Q42620815-14092ECD-247E-4411-B204-E44A060052F6Q44661790-E6FE52F7-40D0-4772-B5D5-9D65437EB334Q46672355-C860E8DB-98FB-4FF6-A4F2-69119EC2F6FEQ53226402-9409517F-5968-454D-9D8F-DF9BB72E4D90Q53323224-069DB6D4-BDDE-49F4-91F9-17F7F852400EQ53332184-B07201D0-6D44-4CF4-913E-D39F55C236A5Q53336921-A66B9B6F-5C75-4EAE-B601-80B2FD6DE6A7Q53343786-1D1727A3-7CA4-466E-91DB-195335A874ABQ54315299-49CF346E-D89A-46E7-99BF-1183D0766742Q54706600-10DC27EE-8735-4544-910C-91E561C6B37BQ58701892-BA8B88EE-86CB-4EA1-BDC4-219E557104E8Q64091077-666BD67F-34DB-4F7B-A1FB-D1C78FD6EEDFQ64244208-121F9086-C254-4555-B06A-54D3925C1D08Q81195191-1EAF35BF-1A6E-4674-8675-FF8F5CA687FEQ89835069-BDDBBC66-F1B6-468E-92A8-878CE38E3360Q91198930-89424C38-864E-47E9-82A3-D3B5BBF31064Q91333605-4310A651-494D-456D-A59E-3A9ECFF74E1A
P50
description
onderzoeker
@nl
researcher
@en
Õ°Õ„ÕæÕ”Õ¦ÕøÕæÕøÕ²
@hy
name
Hiroshi Tazawa
@ast
Hiroshi Tazawa
@en
Hiroshi Tazawa
@es
Hiroshi Tazawa
@nl
Hiroshi Tazawa
@sl
type
label
Hiroshi Tazawa
@ast
Hiroshi Tazawa
@en
Hiroshi Tazawa
@es
Hiroshi Tazawa
@nl
Hiroshi Tazawa
@sl
prefLabel
Hiroshi Tazawa
@ast
Hiroshi Tazawa
@en
Hiroshi Tazawa
@es
Hiroshi Tazawa
@nl
Hiroshi Tazawa
@sl
P1053
B-2247-2011
P106
P31
P3829
P496
0000-0003-4658-1050